Table 1 Characteristics of the study population: women of childbearing age (Training set—Group 1).

From: Exhaled volatilome analysis as a useful tool to discriminate asthma with other coexisting atopic diseases in women of childbearing age

 

Group 1 (211)

A-AD

NA

NA-AD

NA-NAD

Subjects n

25

186

72

114

Age (years), mean (range)

32.4 (20–39)

32.9 (20–43)

32.8 (23–41)

33.0 (20–43)

BMI (kg/m2) before pregnant, mean (range)

25.23 (19.72–36.81)

24.13 (16.23–42.32)

23.59 (16.65–38.67)

24.48 (16.23–42.32)

Social class

Managers-technicians/skilled/semiskilled-unskilled/unemployed, %

36.0/20.0/20.0/24.0

35.5/18.3/22.0/24.2

34.7/15.2/20.8/29.2

36.0/20.2/22.8/21.1

Educational level

Incomplete secondary or less/complete secondary/university %

28.0/12.0/60.0

19.3/25.3/55.4

25.0/27.8/47.2

15.8/23.7/60.5

Smoking during pregnancy, Yes/No n/n

2/23

30/156

9/63

21/93

Smoker, Yes/No n/n

3/22

30/156

8/64

22/92

Other atopic disorders, yes

25 (100%)b

72 (39%)a

72 (100%)

-

Allergic rhinitis, yes

23 (92%)b,c

47 (25%)a

47 (65%)a

-

Atopic dermatitis, yes

8 (32%)b

12 (6%)a

12 (17%)

-

Allergic conjunctivitis, yes

17 (68%)b

26 (14%)a

26 (36%)

-

Food allergy, yes

5 (20%)b

10 (5%)a

10 (14%)

-

Drug allergy, yes

5 (20%)

14 (8%)

14 (19%)

-

Parental asthma, yes

6 (24%)b,d

11 (6%)a

6 (8%)

5 (4%)a

Parental allergic rhinitis, yes

10 (40%)b,d

36 (19%)a

21 (29%)d

15 (13%)a,c

Parental atopic dermatitis, yes

3 (12%)

8 (4%)

2 (3%)

6 (5%)

Antibiotics consumption, yes

11 (44%)

57 (31%)

22 (31%)

35 (31%)

Paracetamol consumption, yes

18 (72%)

107 (56%)

39 (54%)

68 (60%)

Inhaled corticosteroids consumption, yes

2 (8%)

5 (3%)

3 (4%)

2 (2%)

Injectable corticosteroids consumption, yes

2 (8%)

7 (4%)

6 (8%)d

1 (1%)c

Blood leucocyte count /µl, mean (range)

9548 (6380–16,610)

9247 (5270–16,720)

9054 (5270–15,560)

9369 (5270–16,720)

Blood monocyte count /µl, mean (range)

590 (320–1080)

614 (240–1460)

618 (370–1160)

611 (240–1460)

Blood lymphocyte count /µl, mean (range)

1847 (1160–3130)

2017 (770–4290)

2021 (960–3600)

2015 (770–4290)

Blood basophil count /µl, mean (range)

32 (10–60)

31 (0–100)

28 (10–60)

32 (0–100)

Blood eosinophil count /µl, mean (range)

213 (70–350)b,c,d

138 (0–500)a

131 (0–380)a

143 (0–500)a

Blood neutrophil count /µl, mean (range)

6866 (3960–12,780)

6447 (3380–11,360)

6255 (3380–11,360)

6568 (3380–10,970)

Season at sampling

Winter/spring/summer/autumn %

24.0/20.0/20.0/36.0

25.3/10.8/22.0/41.9

38.9/11.1/19.4/30.6 d

16.7/10.5/23.7/49.1 c

  1. A-AD asthmatics with other coexisting atopic diseases; NA non-asthmatics; NA-NAD non-asthmatics without atopic diseases; NA-AD non-asthmatics with other atopic diseases.
  2. aSignificantly different (p-value < 0.05) from asthmatics with coexisting other atopic diseases (A-AD).
  3. bSignificantly different (p-value < 0.05) from non-asthmatics (NA).
  4. cSignificantly different (p-value < 0.05) from non-asthmatics with other atopic diseases (NA-AD).
  5. dSignificantly different (p-value < 0.05) from non-asthmatic without atopic diseases (NA-NAD).